Filed: 9/3/2025ACC: 0001641172-25-026397
Officer· VP, Clinical Trial Operations
Since Jan 2023
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
272.65K acquired · 272.65K disposed
Non-Derivative Transactions0
No non-derivative transactions reported
Derivative Transactions4
Stock Option (Right to Buy)
Direct
Converts to
Common stock
207.65K shares
Shares
−207.65K
Strike price
6.00
Held after
0.00
Exercisable
—
9/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common stock
207.65K shares
Shares
+207.65K
Strike price
3.33
Held after
207.65K
Exercisable
—
9/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common stock
65K shares
Shares
−65K
Strike price
22.40
Held after
0.00
Exercisable
—
9/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common stock
65K shares
Shares
+65K
Strike price
3.33
Held after
65K
Exercisable
—
9/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common stock207.65K shares | 9/1/2025 | D · Disposition | −207.65K | 6.00 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common stock207.65K shares | 9/1/2025 | A · Award | +207.65K | 3.33 | — | 207.65K |
| Stock Option (Right to Buy) Direct | Common stock65K shares | 9/1/2025 | D · Disposition | −65K | 22.40 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common stock65K shares | 9/1/2025 | A · Award | +65K | 3.33 | — | 65K |